Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Movers

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • After-Hours Center
  • Earnings
  • Movers
  • News
  • Restaurants

Cava Group Q1 Earnings: Revenue Beat, EPS Beat, Guidance Raise, Continued Investments In Scalable Infrastructure And More

By Adam Eckert
May 28, 4:27 PM
Cava's first-quarter revenue increased 30.3% year-over-year to $256.3 million, which beat the consensus estimate of $245.935 million, according to Benzinga Pro.

CAVA

Read More
2 minute read
  • Movers
  • News

What’s Going On With Moderna Stock Today?

By Vaishali Prayag
May 28, 3:36 PM
Moderna Inc. (NASDAQ: MRNA) shares are trading lower Tuesday. The stock may be pulling back after gaining on bird flu concerns last week and predictions for a slight rise in COVID-19 cases.

MRNA

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • Movers
  • Trading Ideas

NEAR Protocol Down More Than 3% Within 24 hours

By Benzinga Insights
May 28, 3:03 PM
Over the past 24 hours, NEAR Protocol's (CRYPTO: NEAR) price has fallen 3.17% to $7.59. This continues its negative trend over the past week where it has experienced a 3.0% loss, moving from $7.86 to its current price.

NEAR

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • Movers
  • Trading Ideas

Polkadot Falls More Than 3% In 24 hours

By Benzinga Insights
May 28, 3:02 PM
Over the past 24 hours, Polkadot's (CRYPTO: DOT) price has fallen 3.83% to $7.34. This continues its negative trend over the past week where it has experienced a 3.0% loss, moving from $7.6 to its current price.

$DOT

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • Movers
  • Trading Ideas

Lido Staked Ether Falls More Than 3% In 24 hours

By Benzinga Insights
May 28, 3:02 PM
Over the past 24 hours, Lido Staked Ether's (CRYPTO: STETH) price has fallen 3.31% to $3,794.83. This is opposite to its positive trend over the past week where it has experienced a 2.0% gain, moving from $3,730.84 to its current price.

$STETH

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • Movers
  • Trading Ideas

Bitcoin Decreases More Than 3% Within 24 hours

By Benzinga Insights
May 28, 3:01 PM
Bitcoin's (CRYPTO: BTC) price has decreased 3.0% over the past 24 hours to $67,781.00, continuing its downward trend over the past week of -3.0%, moving from $69,750.12 to its current price.

BTC

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • Movers
  • Trading Ideas

Ethereum Decreases More Than 3% Within 24 hours

By Benzinga Insights
May 28, 3:00 PM
Ethereum's (CRYPTO: ETH) price has decreased 3.25% over the past 24 hours to $3,794.60. This is contrary to the coins performance over the past week where it has experienced an up-trend of 2.0%, moving from $3,730.35 to its current price.

ETH

Read More
2 minute read
  • Analyst Color
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Arcturus Therapeutics’ Early Cystic Fibrosis Trial Results Encouraging – Analyst Cautiously Optimistic

By Vandana Singh
May 28, 2:55 PM
Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung function.

ARCT

Read More
2 minute read
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Top Stories
  • Trading Ideas

With FDA Decision Date Approaching, Analyst Downgrades Sarepta On Balanced Risk And Reward

By Vandana Singh
May 28, 2:40 PM
RBC Capital Markets downgrades Sarepta Therapeutics following increased FDA label expansion expectations for Elevidys and recent stock surge.

PFE

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

Why Is AstraZeneca Stock Trading Lower On Tuesday?

By Vandana Singh
May 28, 2:32 PM
AstraZeneca's TROPION-Lung01 phase 3 trial for datopotamab deruxtecan in NSCLC showed OS improvement in nonsquamous patients. While the overall trial did not reach statistical significance.

AZN

Posts pagination

Previous 1 … 109 110 111 … 2,348 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service